Loading...
Pasithea Therapeutics Corp.
KTTAW•NASDAQ
Healthcare
Biotechnology
$0.02
$0.005(31.25%)
Pasithea Therapeutics Corp. (KTTAW) Quarterly Earnings Reports & Financial Results
Analyze Pasithea Therapeutics Corp.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of Pasithea Therapeutics Corp.’s actual vs. estimated earnings across recent quarters.
No data available
Pasithea Therapeutics Corp. (KTTAW) Quarterly Earnings Details
Detailed breakdown of Pasithea Therapeutics Corp.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.